Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) EBT: 2019-2025

Historic EBT for Legend Biotech (LEGN) over the last 7 years, with Sep 2025 value amounting to -$39.1 million.

  • Legend Biotech's EBT rose 67.68% to -$39.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$222.5 million, marking a year-over-year increase of 35.60%. This contributed to the annual value of -$158.1 million for FY2024, which is 69.60% up from last year.
  • Per Legend Biotech's latest filing, its EBT stood at -$39.1 million for Q3 2025, which was up 68.69% from -$124.8 million recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's EBT ranged from a high of $40.5 million in Q4 2024 and a low of -$198.8 million during Q2 2023.
  • Its 3-year average for EBT is -$85.6 million, with a median of -$99.1 million in 2025.
  • In the last 5 years, Legend Biotech's EBT plummeted by 33,858.75% in 2022 and then soared by 127.59% in 2024.
  • Quarterly analysis of 5 years shows Legend Biotech's EBT stood at -$88.3 million in 2021, then slumped by 53.65% to -$135.7 million in 2022, then declined by 8.17% to -$146.8 million in 2023, then spiked by 127.59% to $40.5 million in 2024, then soared by 67.68% to -$39.1 million in 2025.
  • Its EBT stands at -$39.1 million for Q3 2025, versus -$124.8 million for Q2 2025 and -$99.1 million for Q1 2025.